CXCR4 and renal cell carcinoma: documented that the pharmacological inhibition of NMMHC-IIA using blebbistatin effectively suppressed the nuclear translocation of CXCR4, thereby attenuating the metastatic potential of renal cell carcinoma (RCC) cells 45.